Theoni Trangas

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

Andreas Scorilas, Andreas Karameris, Niki Arnogiannaki et al. · British Journal of Cancer · 2001 · 258 citations · Full text

Expression of oncofetal RNA‐binding protein CRD‐BP/IMP1 predicts clinical outcome in colon cancer

Euthymios Dimitriadis, Theoni Trangas, Stavros Milatos et al. · International Journal of Cancer · 2007 · 85 citations

Pathology, Cancer Biology, Tumor Biology +17

Curcumin analogues as possible anti-proliferative & anti-inflammatory agents

Anna‐Maria Katsori, Maria Chatzopoulou, K. Dimas et al. · European Journal of Medicinal Chemistry · 2011 · 84 citations

Inflammation, Medicinal Chemistry, Anti-inflammatory +6

C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors

Panayotis Ioannidis, Theoni Trangas, Euthymios Dimitriadis et al. · International Journal of Cancer · 2001 · 71 citations · Full text

Labdane type diterpenes down-regulate the expression of c-myc protein, but not of bcl-2, in human leukemia T-cells undergoing apoptosis

Konstantinos Dimas, Costas Demetzos, V Vaos et al. · Leukemia Research · 2001 · 67 citations

Hematological Malignancy, Labdane Type Diterpenes, Signal Transduction +9